Searching for a strong candidate to provide central computational & bioinformatic support to investigations of epigenomic mechanisms & biomarkers of the cancer process. @IARCWHO#Cancer 🧬🧬🧬
For details and to apply, click here👇👇👇
https://t.co/JqAZsoZLHi
Great speech from @IARC_Dir to 🙏 our 🇫🇷 institutional partners, welcome personnel to the Nouveau Centre, & launch a new era of OpenScience! We look forward to welcoming you to the #IARCNC to continue research towards a 🌏 where fewer people develop #cancer
Excited to announce that our Kick-Off Meeting of the Origins & Causes of Childhood Cancer project (PEDIAC, funded by INCA) took place today. Ambitious project aimed at discovering molecular (#epigenetics) origins & #environmental causes of #childhoodcancer
https://t.co/l3u6KTZy2j
New position available in the framework of my ERC StG project #HUMYCO - looking forward to many applications @UGent_Pharma@ERC_Research -> https://t.co/OgwGZh6p0i
Our new article on Wnt is out! A great work by @nicoleylgiebel , @Anchel_91 et al: A tug-of-war between USP42 and the stem cell factor R-spondin controls the tumour suppressors RNF43/ZNRF3. Funded by @dfg_public@AvHStiftung
@sfb1324 @COSHeidelberg
https://t.co/5M2np5GIMU
Warm welcome to Dr Grace Odongo from 🇰🇪 as postdoc in our team at @IARCWHO. Grace won a Children with Cancer UK fellowship to investigate mycotoxins & viruses in childhood cancer from Africa, collab @MartheDeBoevre & @saeger_sarah funded by @FWOVlaanderen https://t.co/vQSSrtqLcH
"When I became a graduate student, I made a point of treating the undergraduates I supervised the way I wish I’d been treated."
In this week's #ScienceWorkingLife, a #PhD student shares three tips for being a thoughtful, supportive mentor. https://t.co/cEjIDWRhOZ
Happy to see our latest paper out today at @NatMetabolism! In this great collaborative work, we show that glycolysis is a main driver in squamous cells carcinoma, with Sirt6 acting as a potent tumor suppressor in these tumors 1/2 https://t.co/RTgTWNquKo
Pleased to welcome @SpitzNatalia from 🇧🇷 as postdoc fellow in our team, Epigenomics & Mechanisms Branch at @IARCWHO. Natália won fellowship from Children with Cancer UK to work on identifying epigenetic biomarkers of early-life factors in association with childhood cancer risk
Proud to share video https://t.co/UJggbbMVDL explaining our project on #childhoodcancer at @IARCWHO & contribute to #InternationalChildhoodCancerDay (ICCD21), raising awareness of importance of identifying causes & cell/molecular origins.
Donate to IARC https://t.co/mWsMEn4G4P
Notice the building under construction in Gerland, Lyon,🇫🇷? Soon @IARCWHO will move to a new HQ built around a concept of Open Science. The new HQ will have ++lab space, ++office space, & room to 2x the size of IARC’s biobank to 10 000 000 samples #IARCNC https://t.co/Iwdw0BlfIi
Congratulations to Dr @ZdenkoHerceg, Head of the Epigenetics Group at IARC, who was awarded the title Professor Honoris Causa of the University of Mostar in recognition of his contributions to #cancer research, international collaboration & #training of young scientists.
It’s #BreastCancerAwarenessMonth! We’re sharing key findings from our #breast#cancer research projects: the ABC-DO study found at least 1/3 of the projected 416K breast #cancer deaths expected in sub-Saharan #Africa in the next 10 yrs could be prevented https://t.co/22fdPNiIIc
New study led by IARC scientists reveals #genes acting as #cancer “drivers” across multiple malignancies. Epigenetic regulator genes, which affect many critical cellular processes, may drive #cancer development when disrupted https://t.co/iq1YS9DjTM